Although there are still many key questions waiting to be addressed, further understanding of the mechanisms by which CPhGs and PI3K/PKB mediate inflammatory responses may shed new light on exploring cardiac hypertrophy treatment in the future. This evidence concerns the gene AKT1 and cardiac hypertrophy.